Business Description
PhoenixBio Co Ltd
ISIN : JP3803010002
Description
PhoenixBio Co Ltd conducts study services for drug discovery and early development. It provides outsourcing services for drug development. The Company uses PXB-Mouse to conduct the study. Its services include pharmacokinetics related test, safety test, hepatitis virus (HBV / HCV) related drug efficacy test.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.74 | |||||
| Equity-to-Asset | 0.67 | |||||
| Debt-to-Equity | 0.26 | |||||
| Debt-to-EBITDA | 7.02 | |||||
| Interest Coverage | 3.78 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | 1.33 | |||||
| Beneish M-Score | -2.81 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 13.1 | |||||
| 3-Year FCF Growth Rate | 29.2 | |||||
| 3-Year Book Growth Rate | 10.3 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 42.74 | |||||
| 9-Day RSI | 38.3 | |||||
| 14-Day RSI | 36.3 | |||||
| 3-1 Month Momentum % | -11.73 | |||||
| 6-1 Month Momentum % | -18.9 | |||||
| 12-1 Month Momentum % | -13.45 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.68 | |||||
| Quick Ratio | 3.65 | |||||
| Cash Ratio | 2.87 | |||||
| Days Inventory | 305.62 | |||||
| Days Sales Outstanding | 52 | |||||
| Days Payable | 14.27 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -7 | |||||
| Shareholder Yield % | 26.49 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 69.67 | |||||
| Operating Margin % | 0.65 | |||||
| Net Margin % | 1.54 | |||||
| FCF Margin % | -6.88 | |||||
| ROE % | 1.53 | |||||
| ROA % | 0.95 | |||||
| ROIC % | 0.34 | |||||
| 3-Year ROIIC % | 178.03 | |||||
| ROC (Joel Greenblatt) % | 5.99 | |||||
| ROCE % | 2.93 | |||||
| Years of Profitability over Past 10-Year | 5 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 108.25 | |||||
| PE Ratio without NRI | 304.51 | |||||
| PS Ratio | 0.81 | |||||
| PB Ratio | 0.87 | |||||
| Price-to-Tangible-Book | 0.85 | |||||
| EV-to-EBIT | 10.53 | |||||
| EV-to-EBITDA | 10.53 | |||||
| EV-to-Revenue | 0.4 | |||||
| EV-to-FCF | -5.8 | |||||
| Price-to-GF-Value | 0.6 | |||||
| Price-to-Projected-FCF | 2.25 | |||||
| Price-to-Graham-Number | 3.38 | |||||
| Price-to-Net-Current-Asset-Value | 1.28 | |||||
| Price-to-Net-Cash | 4.01 | |||||
| Earnings Yield (Greenblatt) % | 9.49 | |||||
| FCF Yield % | -8.19 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
PhoenixBio Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil 円) | 1,715.321 | ||
| EPS (TTM) (円) | 3.288 | ||
| Beta | 0.1 | ||
| 3-Year Sharpe Ratio | -0.48 | ||
| 3-Year Sortino Ratio | -0.66 | ||
| Volatility % | 22.65 | ||
| 14-Day RSI | 36.3 | ||
| 14-Day ATR (円) | 12.867762 | ||
| 20-Day SMA (円) | 358.4 | ||
| 12-1 Month Momentum % | -13.45 | ||
| 52-Week Range (円) | 344 - 580 | ||
| Shares Outstanding (Mil) | 4.05 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
PhoenixBio Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
PhoenixBio Co Ltd Stock Events
| Event | Date | Price (円) | ||
|---|---|---|---|---|
| No Event Data | ||||
PhoenixBio Co Ltd Frequently Asked Questions
What is PhoenixBio Co Ltd(TSE:6190)'s stock price today?
The current price of TSE:6190 is 円352.00. The 52 week high of TSE:6190 is 円580.00 and 52 week low is 円344.00.
When is next earnings date of PhoenixBio Co Ltd(TSE:6190)?
The next earnings date of PhoenixBio Co Ltd(TSE:6190) is .
Does PhoenixBio Co Ltd(TSE:6190) pay dividends? If so, how much?
PhoenixBio Co Ltd(TSE:6190) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers